A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer.
Alexander J LinPamela SamsonTodd DeWeesLauren HenkeThomas BaranskiJulie SchwarzJohn PfeiferPerry GrigsbyStephanie MarkovinaPublished in: Cancer medicine (2018)
Characterization of molecular pathways involved in cPTC tumorigenesis may add further risk stratification for recurrence beyond the 2015 ATA risk categories alone.